AGO2 and breast carcinoma: Other studies have reported that in human neuroblastoma, fibroblast and breast cancer cells, AGO2 can shuttle microRNA from the cytoplasm into the nucleus in order to bind to the targeted gene promoter region as an AGO2-microRNA complex [41,42].